Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer



Status:Completed
Conditions:Prostate Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:8/25/2017
Start Date:April 2013
End Date:February 2016

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer

This is a clinical trial designed to quantify the immune response and determine the
tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for
patients with advanced prostate cancer.


Inclusion Criteria:

- Subjects with advanced prostate cancer who are eligible to receive sipuleucel-T in
accordance with FDA approved labeling of sipuleucel-T

- Subjects must understand and sign an informed consent form

Exclusion Criteria:

- Subjects who are not eligible to receive sipuleucel-T
We found this trial at
1
site
Prostate Oncology Specialists, Inc.
Marina Del Rey, California 90292
?
mi
from
Marina Del Rey, CA
Click here to add this to my saved trials